Large Intestinal Adenoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Conform to the diagnostic criteria for colorectal adenoma and TCM differentiation standards; gender, age between 30 and 75 years; subjects have provided informed consent and signed relevant documents.
Exclusion criteria
Exclusion criteria: Patients who do not meet the above disease diagnostic criteria; patients diagnosed with familial adenomatous polyposis or Peutz-Jeghers syndrome; patients with adenomatous tissue showing carcinogenesis and/or severe atypical hyperplasia as confirmed by pathological examination; patients with a bowel preparation cleanliness grade of Class D during colonoscopy; patients with other severe primary diseases, organ dysfunction, mental disorders, pregnancy or planned pregnancy, lactation, allergic constitutions, or allergies to multiple medications; patients currently participating in other clinical studies; and patients currently taking or requiring to take medications during the study that may affect the efficacy assessment of the investigational drug: metformin, nonsteroidal anti-inflammatory drugs (e.g., aspirin, ibuprofen, diclofenac, etc.), cyclooxygenase-2 inhibitors (e.g., celecoxib, etc.), calcium supplements, and other traditional Chinese medicine decoctions, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Colonoscopy indicators; | — |
Secondary
| Measure | Time frame |
|---|---|
| Symptoms, Signs, and Indicators; | — |
Countries
China
Contacts
Jiangsu Province Hospital of Integration of Chinese and Western Medicine